Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer
Open accessPublished version of a preprint
Abstract
Scribble (SCRIB) localizes to cell–cell junctions and regulates establishment of epithelial cell polarity. Loss of expression of SCRIB functions as a tumor suppressor in Drosophila and mammals; conversely, overexpression of SCRIB promotes epithelial differentiation in mammals. Here, we report that SCRIB is frequently amplified, mRNA overexpressed, and protein is mislocalized from cell–cell junctions in human breast cancers. High levels of SCRIB mRNA are associated with poor clinical prognosis, identifying an unexpected role for SCRIB in breast cancer. We find that transgenic mice expressing a SCRIB mutant [Pro 305 to Leu (P305L)] that fails to localize to cell–cell junctions, under the control of the mouse mammary tumor virus long terminal repeat promoter, develop multifocal hyperplasia that progresses to highly pleomorphic and poorly differentiated tumors with basal characteristics. SCRIB interacts with phosphatase and tensin homolog (PTEN) and the expression of P305L, but not wild-type SCRIB, promotes an increase in PTEN levels in the cytosol. Overexpression of P305L, but not wild-type SCRIB, activates the Akt/mTOR/S6K signaling pathway. Human breast tumors overexpressing SCRIB have high levels of S6K but do not harbor mutations in PTEN or PIK3CA, identifying SCRIB amplification as a mechanism of activating PI3K signaling in tumors without mutations in PIK3CA or PTEN. Thus, we demonstrate that high levels of mislocalized SCRIB functions as a neomorph to promote mammary tumorigenesis by affecting subcellular localization of PTEN and activating an Akt/mTOR/S6kinase signaling pathway. Cancer Res; 74(11); 3180–94. ©2014 AACR.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 35 cited sources checked · 0 supported · 0 flagged
- Findingown data
Of 20 breast cancer samples with moderate to strong SCRIB, 11 had mainly cytosolic SCRIB and 9 had both membrane and cytosolic SCRIB.
“11 of the 20 samples showed predominantly cytosolic SCRIB localization (Fig. 1Eiii), while the remaining nine showed a combination of membrane and cytosolic localization (Fig. 1Ei,ii).”
Quote in the paperSubstantial claim - Findingown data
Mice engineered to express hSCRIBP305L via the MMTV LTR develop multifocal hyperplasia.
“transgenic mice expressing a SCRIB mutant (Pro 305 to Leu (P305L)) that fails to localize to cell-cell junctions, under the control of the mouse mammary tumor virus long terminal repeat promoter, develop multifocal hyperplasia”
Quote in the paperSubstantial claim- Rests on an assumption: The tumorigenic effect in hSCRIBP305L mice is attributable to SCRIB mislocalization rather than to SCRIB overexpression alone.
- Findingown data
In MCF-10A cells expressing wild-type SCRIB, EGF caused a threefold rise in Ser473 phosphorylation by 2.5 minutes, peaking at 5 minutes.
“In cells expressing SCRIBWT, addition of EGF led to three-fold increase Ser473 phosphorylation within 2.5 minutes, with a peak at 5 minutes after stimulation.”
Quote in the paperSubstantial claim - Findingown data
In parental MCF-10A cells, an EGF-induced increase in Akt substrate phosphorylation was detectable at 30 minutes.
“In parental MCF-10A cells, an EGF stimulation-induced increase in substrate phosphorylation was detectable by 30 minutes.”
Quote in the paperNot a substantial claim - Findingown data
Mammary glands from hSCRIBP305L mice had more SCRIB protein than those from control mice.
“hSCRIBP305L mice displayed higher levels of SCRIB protein in the mammary gland than control mice.”
Quote in the paperSubstantial claim
- Findingown data
Without genomic amplification, SCRIB mRNA was upregulated in 68 samples (9.1%).
“SCRIB mRNA was upregulated, in the absence of genomic amplification, in 68 samples (9.1%).”
Quote in the paperNot a substantial claim - Findingown data
SCRIBWT and hSCRIBP305L both failed to alter EGF-stimulated JNK or p38 phosphorylation.
“neither SCRIBWT nor hSCRIBP305L modified EGF-stimulated JNK or p38 kinase phosphorylation (data not shown).”
Quote in the paperNot a substantial claim - Findingown data
In hSCRIBP305L cells, PRAS40 phosphorylation was enhanced and sustained at all tested time points compared with control or wild-type SCRIB cells.
“In MCF-10A cells expressing hSCRIBP305L, PRAS40 phosphorylation was both enhanced and sustained at all time points tested, as compared with control cells or those expressing SCRIBWT.”
Quote in the paperSubstantial claim - Findingown data
One of the 14 hSCRIBP305L tumor-bearing mice had intravascular tumor emboli in the lung.
“one of the 14 hSCRIBP305L tumor-bearing mice revealed intravascular tumor emboli in lung tissue (Fig. 5D)”
Quote in the paperNot a substantial claim - Findingown data
All six hSCRIBP305L tumors analyzed had lower GATA3 and CK18 expression than NDL tumors.
“all samples analyzed (6/6) expressed decreased levels of these markers compared with NDL tumors (Fig. 5G).”
Quote in the paperSubstantial claim - Findingown data
All six hSCRIBP305L tumors showed 10- to 60-fold higher expression of at least two basal markers.
“all six hSCRIBP305L tumors analyzed expressed dramatically enhanced levels (10- to 60-fold increase) of at least two of these basal markers.”
Quote in the paperSubstantial claim - Findingown data
In MCF10A and wild-type SCRIB cells, EGF did not significantly increase p70S6K phosphorylation up to 45 minutes.
“In contrast, in MCF10A cells, and those expressing SCRIBWT, EGF stimulation did not significantly increase p70S6K phosphorylation up to 45 minutes after stimulation.”
Quote in the paperSubstantial claim - Findingown data
hSCRIBP305L-expressing MCF-10A cells showed a marked rise in Akt308 phosphorylation relative to control or SCRIBWT cells.
“MCF-10A cells expressing hSCRIBP305L displayed a marked increase in Akt308 phosphorylation as compared with either control or SCRIBWT cells (Fig. 6C).”
Quote in the paperSubstantial claim - Findingown data
P305L expression, unlike wild-type SCRIB, raises cytosolic PTEN levels.
“the expression of P305L, but not wild-type SCRIB, promotes an increase in PTEN levels in the cytosol.”
Quote in the paperSubstantial claim - Findingown data
Breast cancers with high SCRIB mRNA levels have a worse clinical prognosis.
“High levels of SCRIB mRNA are associated with poor clinical prognosis”
Quote in the paperSubstantial claim - Findingown data
In P305L2, tumor penetrance reached 55% by two years of age.
“Penetrance of the tumor phenotype reached as high as 55% by two years of age in P305L2”
Quote in the paperSubstantial claim - Findingown data
In parental MCF-10A cells, Akt Ser473 phosphorylation occurs within five minutes of EGF stimulation.
“In parental MCF-10A cells, Akt is phosphorylated at Ser473 within 5 minutes of EGF stimulation (Fig. 6C).”
Quote in the paperNot a substantial claim - Findingown data
EGF-stimulated ERK phosphorylation had similar kinetics and amplitude in SCRIBWT- and hSCRIBP305L-expressing cells.
“The kinetics and amplitude of EGF-stimulated ERK phosphorylation was similar in cells expressing either SCRIBWT or hSCRIBP305L.”
Quote in the paperNot a substantial claim - Findingown data
In adult virgin FVB mice, SCRIB co-localizes with E-cadherin at the basolateral surface of luminal epithelial cells.
“In adult virgin mammary glands of FVB mice, SCRIB co-localizes with E-cad to the basolateral surface of luminal epithelial cells (Fig. 2C,D, left panels).”
Quote in the paperSubstantial claim - Findingown data
In hSCRIBP305L mice, SCRIB is mainly expressed in E-cadherin-positive luminal epithelial cells.
“In hSCRIBP305L mice, SCRIB expression in the mammary gland was primarily expressed in E-cad positive luminal epithelial cells (Fig. 2C,D, right panels).”
Quote in the paperNot a substantial claim - Findingown data
In SCRIBWT-expressing MCF-10A cells, EGF addition produced higher Akt308 phosphorylation.
“In MCF-10A cells expressing SCRIBWT, addition of EGF led to higher levels of Akt308 phosphorylation (Fig. 6C).”
Quote in the paperSubstantial claim - Findingown data
hSCRIBP305L-expressing cells showed a larger increase in Akt substrate phosphorylation than parental or wild-type SCRIB cells.
“However, cells expressing hSCRIBP305L showed a greater increase in signal compared to those observed in parental or SCRIBWT expressing cells (Supp. Fig 4A)”
Quote in the paperSubstantial claim - Findingown data
SCRIB interacts with PTEN.
“SCRIB interacts with PTEN”
Quote in the paperSubstantial claim - Findingown data
Through 50 weeks, hSCRIBP305L mice showed significantly impaired tertiary side branching relative to controls.
“Quantitative analysis of hSCRIBP305L mice through 50 weeks of age demonstrated a significant impairment in tertiary side branching as compared with control mice (Fig. 3B).”
Quote in the paperSubstantial claim - Findingown data
hSCRIBP305L cells showed enhanced p70S6K and S6 phosphorylation 45 minutes after EGF compared with MCF-10A or wild-type SCRIB cells.
“MCF-10A cells expressing hSCRIBP305L displayed enhanced phosphorylation of p70S6K and S6 45 minutes after EGF stimulation, as compared with MCF-10A cells or MCF-10A cells expressing SCRIBWT (Fig. 6F).”
Quote in the paperSubstantial claim - Findingown data
Regions of hyperplastic growth developed in virgin hSCRIBP305L mice but not in FVB controls.
“Virgin hSCRIBP305L mice, but not FVB control mice, developed regions of hyperplastic growth, as determined by whole mount carmine alum-stained mammary glands (Fig. 4A) and H&E-stained sections (Fig. 4B).”
Quote in the paperSubstantial claim - Findingown data
Without EGF, MCF-10A cells showed no detectable Akt Thr308 phosphorylation.
“In MCF-10A cells grown in the absence of EGF, phosphorylation of Akt at Thr308 was undetectable (Fig. 6C).”
Quote in the paperNot a substantial claim - Findingown data
SCRIB was significantly upregulated in BL1 and M subtypes relative to BL2, IM, MSL, and LAR.
“Here we find that SCRIB was significantly upregulated in Basal-like 1 (BL1) and Mesenchymal (M), as compared with Basal-like 2 (BL2), Immunomodulatory (IM), Mesenchymal stem-like (MSL) and Luminal androgen receptor (LAR) (Fig. 1C, Supp. Figs. 1D,E)”
Quote in the paperSubstantial claim - Findingown data
In these mice, the hyperplasia advances to highly pleomorphic, poorly differentiated tumors that have basal features.
“that progresses to highly pleomorphic and poorly differentiated tumors with basal characteristics”
Quote in the paperSubstantial claim- Rests on an assumption: The tumorigenic effect in hSCRIBP305L mice is attributable to SCRIB mislocalization rather than to SCRIB overexpression alone.
- Findingown data
hSCRIBP305L cells showed p70S6K phosphorylation as early as 15 minutes after EGF, maintained through 45 minutes.
“MCF-10A cells expressing hSCRIBP305L displayed phosphorylation of p70S6K as early as 15 minutes following EGF stimulation, which was maintained through 45 minutes (Fig 6E).”
Quote in the paperSubstantial claim - Findingown data
The hyperplasia phenotype was highly penetrant, appearing in 8 of 10 transgenic mice over one year old.
“the hyperplasia phenotype was highly penetrant and observed in 8/10 transgenic mice older than one year of age (Fig. 4C).”
Quote in the paperSubstantial claim - Findingown data
By 18 months, virgin hSCRIBP305L mice from two separate lines developed focal mammary tumors.
“Within one and a half years of age, virgin hSCRIBP305L mice from two distinct lines developed focal mammary tumors (Fig. 5A).”
Quote in the paperSubstantial claim - Findingown data
Within luminal epithelial cells of hSCRIBP305L mice, SCRIB is distributed throughout the cytosol.
“However, within the luminal epithelial cells of hSCRIBP305L mice, SCRIB is localized throughout the cytosol (Fig. 2D).”
Quote in the paperSubstantial claim - Findingown data
hSCRIBP305L expression enhanced EGF-induced TSC2 phosphorylation compared with MCF-10A and wild-type SCRIB cells.
“Expression of hSCRIBP305L enhanced EGF-induced phosphorylation of TSC2, as compared with MCF-10A cells and those expressing SCRIBWT (Fig. 6D).”
Quote in the paperSubstantial claim - Findingown data
Basal and luminal B tumors had significantly higher SCRIB expression than luminal A, Her2, and normal-like tumors.
“we observed that SCRIB expression was significantly higher in the basal and luminal B tumors, as compared with luminal A, Her2 and normal-like tumors.”
Quote in the paperSubstantial claim - Findingown data
In breast cancer, high SCRIB expression predicts worse overall survival (HR = 1.61, p < 0.0007).
“high SCRIB expression predicts for worse overall survival (HR = 1.61, p < 0.0007; Fig 1D).”
Quote in the paperSubstantial claim - Findingown data
hSCRIBP305L tumors had enhanced S6 phosphorylation compared with NDL controls.
“hSCRIBP305L tumors displayed enhanced phosphorylation of S6, as compared with NDL controls.”
Quote in the paperSubstantial claim - Findingown data
SCRIB amplification did not correlate with HER2 amplification in human breast cancer (p=0.06, n=760).
“By contrast, SCRIB amplification did not correlate with HER2 amplification in human breast cancer (p=0.06, n=760).”
Quote in the paperNot a substantial claim - Findingown data
Western blots of mammary glands at 30 weeks and hyperplastic glands at 75 weeks showed higher phospho-S6 in hSCRIBP305L glands.
“Western blot analysis of mammary glands isolated from FVB and hSCRIBP305L mice at 30 weeks (Fig. 7H), and hyperplastic glands at 75 weeks (Fig. 7I) showed higher levels of phospho-S6 in hSCRIBP305L glands.”
Quote in the paperSubstantial claim - Findingown data
Endogenous SCRIB immunoprecipitated endogenous PTEN.
“Whereas no PTEN was pulled down in the control IP (IgG), endogenous SCRIB was able to pull down endogenous PTEN.”
Quote in the paperSubstantial claim - Findingown data
IHC showed enhanced phospho-Akt308 in hSCRIBP305L tumors.
“In addition, IHC analysis showed enhanced phospho-Akt308 in hSCRIBP305L tumors (Fig. 7K).”
Quote in the paperSubstantial claim - Findingown data
Human tumors with SCRIB amplification had higher phosphorylated S6 than non-amplified tumors.
“Similar to our findings with mouse tumors induced by expressing mislocalized SCRIB, tumors with SCRIB amplification had higher levels of phosphorylated S6 as compared to non-amplified tumors (Fig. 7L).”
Quote in the paperSubstantial claim - Findingown data
Sequencing efforts and TCGA data show no evidence of frequent SCRIB mutations.
“Our sequencing efforts and those reported by TCGA do not show evidence of frequent mutations in SCRIB suggesting that changes in Scribble localization must involve alternate mechanisms.”
Quote in the paperSubstantial claim - Findingown data
Rapamycin inhibited mTORC1-mediated phosphorylation of p70S6K and S6.
“In the presence of rapamycin, mTORC1-mediated phosphorylation of p70S6K and S6 proteins was inhibited (Fig 6F).”
Quote in the paperSubstantial claim - Findingown data
Mutation of the first PDZ domain of SCRIB significantly reduced the SCRIB/PTEN interaction.
“Whereas GFP-PTEN was able to bind T7-WTSCRIB, or PDZ mutants P2, P3 and P4, mutation of the first PDZ domain of SCRIB significantly reduced the SCRIB/PTEN interaction (Fig. 7D,E).”
Quote in the paperSubstantial claim - Findingown data
Transgenic mice co-expressing hSCRIBP305L and NEU/HER2 under the MMTV promoter showed no change in tumor onset latency.
“Consistently, we find that transgenic mice co-expressing hSCRIBP305L and NEU/HER2 under the control of MMTV promoter did not show any change in latency of tumor onset (Supp. Fig. 4C)”
Quote in the paperSubstantial claim - Findingown data
SCRIB amplification correlated with alterations in TP53, BRCA1, BRCA2, FGFR1, EGFR, MAP3K1, and ZNF217.
“SCRIB amplification correlated with alterations in TP53, BRCA1, BRCA2, FGFR1, EGFR, MAP3K1 and ZNF217, demonstrating a correlation between SCRIB amplification and genes frequently altered in aggressive forms of breast cancer.”
Quote in the paperSubstantial claim - Findingown data
SCRIB and MYC co-amplification showed a strong correlation in human breast cancer (p=0, n=760).
“Consistent with this observation, there was a strong correlation between SCRIB and MYC co-amplification in human breast cancer (p=0, n=760) (Fig. 7M).”
Quote in the paperSubstantial claim - Findingown data
At eight weeks, pS6 staining intensity did not differ between FVB and hSCRIBP305L mice.
“At the eight-week time point, no change was seen in the intensity of pS6 staining between FVB and hSCRIBP305L mice.”
Quote in the paperNot a substantial claim - Findingown data
hSCRIBP305L cells had more than threefold more cytosolic PTEN than parental or wild-type SCRIB cells.
“MCF-10A cells expressing hSCRIBP305L had a more than three-fold increase in cytosolic PTEN than the parental or WTSCRIB expressing cells (Fig. 7F, left panels).”
Quote in the paperSubstantial claim - Findingown data
Rapamycin did not affect mTORC2-mediated Akt Ser473 phosphorylation.
“As expected, mTORC2 mediated phosphorylation of Akt at 473 was not affected in rapamycin treated cells (Fig 6G).”
Quote in the paperNot a substantial claim - Premisecitation
In several human cancers-breast, prostate, and colon-hSCRIB protein is mislocalized away from cell-cell junctions.
“hSCRIB protein is mislocalized from cell-cell junctions in multiple human cancers, including breast, prostate and colon (2, 3).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [2] Zhan, 2008, Deregulation of Scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma, Cell source
Not checked in the free run.
- cites [3] Pearson, 2011, SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia, J Clin Invest source
Not checked in the free run.
- Interpretationown data
SCRIB mislocalization specifically activates the Akt/mTOR pathway and downstream targets in mammary epithelial cells.
“Therefore, SCRIB mislocalization specifically induces activation of Akt/mTOR pathway that leads to activation of downstream targets in mammary epithelial cells.”
Quote in the paperSubstantial claim- Rests on an assumption: Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.
- Interpretationown data
Mislocalized SCRIB overexpression can start tumorigenesis in the mouse mammary gland.
“demonstrating that overexpression of mislocalized SCRIB can initiate tumorigenesis in the mouse mammary gland.”
Quote in the paperSubstantial claim- Rests on an assumption: The tumorigenic effect in hSCRIBP305L mice is attributable to SCRIB mislocalization rather than to SCRIB overexpression alone.
- Rests on an assumption: The hSCRIBP305L transgene is the cause of the mammary tumors, not spontaneous or insertional mutagenesis.
- Interpretationown data
In breast tumors, SCRIB is often amplified or overexpressed rather than lost or downregulated.
“These observations demonstrated that the SCRIB gene is frequently amplified or overexpressed and not lost or downregulated in breast tumors.”
Quote in the paperSubstantial claim - Premisecitation
Prostate cancer patients with hSCRIB mislocalization have worse survival.
“In prostate cancer, hSCRIB mislocalization is correlated with poor patient survival (3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Pearson, 2011, SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia, J Clin Invest source
Not checked in the free run.
- Interpretationown data
Mislocalized SCRIB expression leads to accumulation of luminal progenitor cells in the mammary gland.
“our results suggest that expression of mislocalized SCRIB results in accumulation of luminal progenitor cells in the mammary gland.”
Quote in the paperSubstantial claim - Interpretationown data
Mislocalized SCRIB overexpression disrupts mammary gland morphogenesis.
“These results demonstrate that overexpression of mislocalized SCRIB disrupts mammary gland morphogenesis.”
Quote in the paperSubstantial claim - Premisecitation
SCRIB localizes to cell-cell junctions in epithelial cells.
“In epithelial cells, SCRIB localizes to cell-cell junctions”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Zeitler, 2004, Domains controlling cell polarity and proliferation in the Drosophila tumor suppressor Scribble, J Cell Biol source
Not checked in the free run.
- Interpretationreasoning
Normal SCRIB function in both Drosophila and mammals depends on basolateral membrane localization.
“These observations demonstrate that basolateral membrane localization is required for normal SCRIB function in both Drosophila and mammals.”
Quote in the paperSubstantial claim - Premisecitation
In Drosophila epithelial cells, mislocalized SCRIB produces the same phenotype as a complete null.
“mislocalization of SCRIB phenocopies a complete null phenotype in Drosophila (11)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Zeitler, 2004, Domains controlling cell polarity and proliferation in the Drosophila tumor suppressor Scribble, J Cell Biol source
Not checked in the free run.
- Interpretationown data
Amplification of SCRIB can activate PI3K signaling in tumors that lack PIK3CA or PTEN mutations.
“identifying SCRIB amplification as a mechanism of activating PI3K signaling in tumors without mutations in PIK3CA or PTEN.”
Quote in the paperSubstantial claim - Interpretationown data
hSCRIBP305L expression activates Akt in MCF-10A cells.
“suggesting that expression of hSCRIBP305L activates Akt in MCF-10A cells.”
Quote in the paperSubstantial claim- Rests on an assumption: Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.
- Interpretationown data
Multiple mechanisms likely dysregulate SCRIB localization in cancer cell lines and human tumors.
“It is likely that SCRIB localization is dysregulated by multiple mechanisms in cancer cell lines and human tumors.”
Quote in the paperNot a substantial claim - Interpretationown data
SCRIB mislocalization activates the mTORC1/Akt/S6K pathway.
“We report that mislocalization of SCRIB results in acquisition of a new function (neomorph), it mislocalizes PTEN and activates a mTORC1/Akt/S6K pathway and thus results in a gain of function.”
Quote in the paperSubstantial claim- Rests on an assumption: Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.
- Interpretationreasoning
These observations help explain why high SCRIB levels are frequently selected for in breast cancers.
“Together, these observations begin to explain why high levels of SCRIB are frequently selected-for in breast cancers.”
Quote in the paperSubstantial claim- Rests on an assumption: SCRIB mislocalization is highly prevalent in human tumors.
- Premisecitation
Basal-like cancers rarely have PIK3CA mutations.
“Despite high pathway activity, basal-like cancers rarely display PIK3CA (PI3K catalytic domain) mutations (48).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [48] Stemke-Hale, 2008, An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer, Cancer Res source
Not checked in the free run.
- Interpretationown data
SCRIB amplification or overexpression is associated with aggressive subtypes of human breast cancer.
“Taken together our observations demonstrate that amplification or overexpression of SCRIB is associated with aggressive subtypes of human breast cancer”
Quote in the paperSubstantial claim - Interpretationreasoning
SCRIB mislocalization results in a gain of function.
“We report that mislocalization of SCRIB results in acquisition of a new function (neomorph), it mislocalizes PTEN and activates a mTORC1/Akt/S6K pathway and thus results in a gain of function.”
Quote in the paperSubstantial claim - Interpretationown data
The results identify mTOR and Akt signaling as downstream effectors of hSCRIBP305L expression.
“The above results, taken together, identify mTOR and Akt signaling as downstream effectors of expression of hSCRIBP305L.”
Quote in the paperSubstantial claim- Rests on an assumption: Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.
- Interpretationown data
SCRIB mislocalization gives SCRIB a new function (neomorph).
“We report that mislocalization of SCRIB results in acquisition of a new function (neomorph), it mislocalizes PTEN and activates a mTORC1/Akt/S6K pathway and thus results in a gain of function.”
Quote in the paperSubstantial claim - Premisecitation
A mouse model with direct PI3K activation via membrane-recruited p110α developed alveolar hyperplasia and low-penetrance tumorigenesis.
“Furthermore, a mouse model in which direct activation of PI3K was accomplished by recruitment of p110α to the membrane resulted in alveolar hyperplasia and low penetrance tumorigenesis (45).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Renner, 2008, Activation of phosphatidylinositol 3-kinase by membrane localization of p110α predisposes mammary glands to neoplastic transformation, Cancer Res source
Not checked in the free run.
- Interpretationown data
The study identifies an unexpected role for Scribble in cancer pathogenesis.
“Herein, we identify an unexpected role for the polarity protein Scribble in the pathogenesis of cancer.”
Quote in the paperSubstantial claim - Premisecitation
Phosphorylation of serine residues in SCRIB's carboxy-terminal domain causes mislocalization to the cytosol.
“Phosphorylation of serine residues in the carboxy terminal domain of SCRIB induces mislocalization to the cytosol (41).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Metodieva, 2013, CD74-dependent deregulation of the tumor suppressor Scribble in human epithelial and breast cancer cells, Neoplasia source
Not checked in the free run.
- Interpretationreasoning
The results are consistent with a model in which aberrant Akt activation in the mouse mammary gland produces basal-like tumors.
“Therefore, our results are consistent with a model in which aberrant Akt activation within the mouse mammary gland results in basal-like tumors.”
Quote in the paperSubstantial claim- Rests on an assumption: Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.
- Interpretationown data
SCRIB amplification correlates with genes frequently altered in aggressive breast cancers.
“demonstrating a correlation between SCRIB amplification and genes frequently altered in aggressive forms of breast cancer.”
Quote in the paperSubstantial claim - Premisecitation
hSCRIBP305L expression cooperates with Myc in transforming mammary epithelial cells.
“We have previously shown that expression of hSCRIBP305L cooperates with Myc during transformation of mammary epithelial cells (2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Zhan, 2008, Deregulation of Scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma, Cell source
Not checked in the free run.
- Interpretationown data
The C-terminal PDZ-binding site of PTEN is critical for the SCRIB/PTEN interaction.
“T7-SCRIB was able to pull down WT-PTEN, but significantly less PTEN-399, demonstrating that the C-terminal PDZ binding site of PTEN is critical for the SCRIB/PTEN interaction.”
Quote in the paperSubstantial claim - Interpretationown data
SCRIB mislocalization mislocalizes PTEN.
“We report that mislocalization of SCRIB results in acquisition of a new function (neomorph), it mislocalizes PTEN and activates a mTORC1/Akt/S6K pathway and thus results in a gain of function.”
Quote in the paperSubstantial claim - Premisecitation
PTEN knockdown in normal mammary epithelial cells implanted into humanized mouse fat pads caused disorganized, hyperplastic lesions.
“Knockdown of PTEN in normal mammary epithelial cells implanted into humanized mouse fat pads resulted in disorganized, hyperplastic lesions (44).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Korkaya, 2009, Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling, PLoS Biol source
Not checked in the free run.
- Interpretationown data
PTEN localization modulates EGF-induced Akt activation.
“These results suggest that PTEN localization modulates EGF-induced activation of Akt.”
Quote in the paperSubstantial claim - Interpretationcitation
The results that SCRIB mislocalization enhances Akt signaling and causes mammary morphogenesis defects are consistent with a mouse model of Akt pathway activation.
“Our results showing that SCRIB mislocalization enhances Akt signaling and results in mammary morphogenesis defects are consistent with a mouse model of Akt pathway activation (43).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Schwertfeger, 2001, Mammary gland involution is delayed by activated Akt in transgenic mice, Mol Endocrinol source
Not checked in the free run.
- Rests on an assumption: Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.
- Interpretationown data
Overexpressed mislocalized SCRIB activates an mTORC1/Akt/S6K pathway in culture and in vivo.
“We demonstrate that overexpression of a mislocalized form of SCRIB functions as a neomorph by interacting with another tumor suppressor, PTEN, and activating an mTORC1/Akt/S6K signaling pathway in culture and in vivo.”
Quote in the paperSubstantial claim- Rests on an assumption: Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.
- Interpretationown data
SCRIB and PTEN form a protein complex that requires PTEN's PDZ-binding motif and SCRIB's first PDZ domain.
“Taken together, our results suggest that SCRIB and PTEN are present in a protein complex requiring the PDZ-binding motif of PTEN and the first PDZ domain of SCRIB.”
Quote in the paperSubstantial claim - Interpretationown data
hSCRIBP305L and HER2 do not cooperate during mouse mammary tumorigenesis.
“demonstrating lack of cooperation between hSCRIBP305L and HER2 during mouse mammary tumorigenesis.”
Quote in the paperSubstantial claim - Premisecitation
Alterations in SCRIB binding partners, including E-cadherin, may disrupt SCRIB membrane localization.
“Furthermore, alterations in SCRIB binding partners, including E-cadherin, may disrupt SCRIB membrane localization (42).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Navarro, 2005, Junctional recruitment of mammalian Scribble relies on E-cadherin engagement, Oncogene source
Not checked in the free run.
- Interpretationreasoning
Changes in Scribble localization must involve mechanisms other than frequent mutation.
“suggesting that changes in Scribble localization must involve alternate mechanisms.”
Quote in the paperSubstantial claim - Interpretationreasoning
Multiple distinct mechanisms may explain the high prevalence of SCRIB mislocalization in human tumors.
“Therefore, multiple distinct mechanisms may account for the high prevalence of SCRIB mislocalization observed human tumors.”
Quote in the paperNot a substantial claim- Rests on an assumption: SCRIB mislocalization is highly prevalent in human tumors.
- Interpretationown data
SCRIB amplification is mutually exclusive with other mechanisms that activate PI3K signaling.
“suggesting that SCRIB amplification is mutually exclusive with alternate mechanisms of activating the PI3K signaling pathway (Fig. 7M).”
Quote in the paperSubstantial claim
- May combine two claims. 43
- Classified as probably not a substantial claim. 12
- The quote only partly states this claim. 1
May combine two claims.
Findingown dataMDA-MB-231, T47D, and MCF7 cancer cell lines all had mislocalized SCRIB, with no mutations in the Pro 305-containing LRR domain.
“While the cancer cell lines all showed mislocalized SCRIB, no mutations within the Pro 305-containing LRR domain were found (data not shown).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe 14 hSCRIBP305L tumors included adenocarcinomas (29%), spindle cell tumors (14%), adenosquamous carcinoma (21%), cystic squamous cell carcinoma (14%), and unclassified cases (21%).
“The tumors were broadly classified as adenocarcinomas (29%), spindle cell tumors (14%), adenosquamous carcinoma (21%), and cystic squamous cell carcinoma (14%), while the remainder did not fall into simple classification (21%) (Fig. 5C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn MCF-10A cells expressing hSCRIBP305L, Ser473 phosphorylation rose ninefold at 2.5 minutes, stayed elevated through 5 minutes, and fell by 15 minutes.
“MCF-10A cells expressing hSCRIBP305L displayed a nine fold increase of Ser473 phosphorylation at 2.5 minutes that was maintained through 5 minutes and decreased by 15 minutes”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn MCF-10A cells, EGF stimulation caused ERK phosphorylation by 2.5 minutes that persisted to 15 minutes.
“EGF-stimulation of MCF-10A cells promoted ERK phosphorylation within 2.5 minutes, which was maintained through 15 minutes (Fig. 6C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataHuman breast tumors with SCRIB overexpression show high S6K and lack PTEN or PIK3CA mutations.
“Human breast tumors overexpressing SCRIB have high levels of S6K but do not harbor mutations in PTEN or PIK3CA”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataP305L overexpression, but not wild-type SCRIB overexpression, turns on Akt/mTOR/S6K signaling.
“Overexpression of P305L, but not wild type SCRIB, activates the Akt/mTOR/S6K signaling pathway.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOverexpressed SCRIBWT goes to the cell membrane and concentrates at cell-cell junctions, while hSCRIBP305L is mainly cytosolic.
“Overexpressed SCRIBWT localizes to the cell membrane and is concentrated at cell-cell junctions, whereas hSCRIBP305L is predominantly localized to the cytosol (Fig. 6B).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown datahSCRIBP305L cells showed enhanced S6 phosphorylation compared with parental or wild-type SCRIB cells.
“Consistently, MCF-10A cells expressing hSCRIBP305L displayed enhanced phosphorylation of S6, as compared with parental MCF-10A cells or MCF-10A cells expressing SCRIBWT (Fig. 6E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn MCF-10A cells, EGF induced PRAS40 phosphorylation within 2.5 minutes, which returned near baseline by 30 minutes.
“In MCF-10A cells, EGF stimulation induced PRAS40 phosphorylation within 2.5 minutes, returning to near basal levels by 30 minutes (Fig. 6D).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataHistological features varied both between tumors and within tumors.
“We observed both inter-tumor and intra-tumor heterogeneity for histological characteristics (Fig. 5B, insets).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown datahSCRIBP305L tumors had less E-cadherin and more Vimentin and CK14.
“hSCRIBP305L tumors expressed lower levels of E-cadherin and high levels of Vimentin and CK14.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAdding EGF to MCF-10A cells raised Akt308 phosphorylation by 2.5 minutes, it fell after 5 minutes, and returned to baseline by 15 minutes.
“Addition of EGF to the cells led to an increase in Akt308 phosphorylation within 2.5 minutes, reduced after 5 minutes and returned to basal levels by 15 minutes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn hSCRIBP305L mice, CD49flo/CD61+ cells made up 17.1% of the population, 57% more than in FVB controls.
“This population accounted for 17.1% of cells in hSCRIBP305L mice, a 57% increase over FVB controls.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHyperplastic hSCRIBP305L mammary glands had more CK18-positive and double-positive cells and fewer CK14-positive cells.
“In contrast, hyperplastic hSCRIBP305L mammary glands showed increased levels of CK18-positive and double positive cells, with a decrease in the percentage of CK14-positive cells (Fig. 4D,E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn human breast cancers, SCRIB is often amplified, its mRNA is over-expressed, and its protein is mislocalized away from cell-cell junctions.
“SCRIB is frequently amplified, mRNA over-expressed and protein is mislocalized from cell-cell junctions in human breast cancers.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn 748 breast cancer samples, SCRIB was amplified in 116 (15.6%), homozygously deleted in two (0.3%), and had a somatic frame shift mutation in one.
“Among the 748 breast cancer samples analyzed, SCRIB was amplified in 116 tumors (15.6%), homozygous deleted in two (0.3%) and contained a somatic frame shift mutation in one (Fig. 1A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn wild-type SCRIB cells, EGF induced PRAS40 phosphorylation with similar kinetics and intensity, but it was greater at 30 minutes.
“In MCF-10A cells expressing SCRIBWT, EGF induced PRAS40 phosphorylation with similar kinetics and intensity but greater at 30 minutes after EGF-stimulation.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDuctal structures from 20-week-old hSCRIBP305L mice had markedly higher pS6 staining than controls, and this remained elevated through 50 weeks.
“However, ductal structures from 20-week old hSCRIBP305L mice displayed markedly higher pS6 staining than controls, and maintained this enhanced signal through 50 weeks.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSCRIB amplification did not correlate with PTEN mutations (P=0.2, n=760) or PIK3CA mutations (p=0.3, n=482).
“Interestingly, there was no correlation between amplification of SCRIB and mutations in PTEN (P=0.2, n=760) and PIK3CA (p=0.3, n=482), regulators of the PI3K signaling pathway,”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataT7-SCRIB pulled down wild-type PTEN but significantly less PTEN-399.
“T7-SCRIB was able to pull down WT-PTEN, but significantly less PTEN-399, demonstrating that the C-terminal PDZ binding site of PTEN is critical for the SCRIB/PTEN interaction.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWild-type PTEN, but not PTEN-399, attenuated EGF-induced Akt phosphorylation.
“Expression of WT-PTEN, but not PTEN-399, attenuated EGF-induced phosphorylation of Akt (Fig. 7G).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth wild-type SCRIB and hSCRIBP305L pulled down PTEN.
“Importantly, both SCRIBWT and hSCRIBP305L were able to pull down PTEN.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAkt phosphorylates PRAS40 at Thr246, which relieves PRAS40's inhibition of mTORC1.
“Akt directly phosphorylates PRAS40 at Thr246, relieving the PRAS40 inhibitory effect on the mTOR1 complex (mTORC1) (30).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Sancak, 2007, PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase, Mol Cell source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe tumor cells are malignant and can extravasate from the primary site.
“suggesting that the tumor cells are not benign and have the capacity to extravasate from the primary site.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOverexpression of SCRIB promotes epithelial differentiation in mammals.
“overexpression of SCRIB in mammary epithelial cells promotes epithelial differentiation by suppressing expression of epithelial mesenchymal transition regulators in a Ras/MAPK dependent manner (4).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Elsum, 2013, Scribble regulates an EMT polarity pathway through modulation of MAPK-ERK signaling to mediate junction formation, J Cell Sci
Not checked in the free run.
May combine two claims.
PremisecitationLoss of SCRIB expression functions as a tumor suppressor in Drosophila and mammals.
“Loss of SCRIB that results in uncontrolled proliferation and tissue growth identifying it as tumor suppressor (1).”
- Also stated in: § Introduction · plain
“In mammals, loss of SCRIB induces dysplastic growth in vivo (2, 3) identifying loss of expression as a tumor suppressive mechanism.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [1] Bilder, 2000, Localization of apical epithelial determinants by the basolateral PDZ protein Scribble, Nature source
Not checked in the free run.
- cites [2] Zhan, 2008, Deregulation of Scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma, Cell source
Not checked in the free run.
- cites [3] Pearson, 2011, SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia, J Clin Invest source
Not checked in the free run.
- Also stated in: § Introduction · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationmTOR phosphorylates p70S6K at multiple residues, increasing its kinase activity.
“mTOR phosphorylates p70S6 kinase (p70S6K) at several residues, resulting in increased kinase activity (31).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] Pullen, 1998, Phosphorylation and activation of p70s6k by PDK1, Science source
Not checked in the free run.
May combine two claims.
Interpretationown dataAkt kinase is activated early in both wild-type SCRIB and hSCRIBP305L cells, but the activation lasts longer in hSCRIBP305L cells.
“suggesting that Akt kinase is activated early in both SCRIBWT and hSCRIBP305L expressing cells but sustained longer in cells expressing hSCRIBP305L.”
Quote in the paperSubstantial claim- Rests on an assumption: Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationActive p70S6K phosphorylates ribosomal protein S6, which increases translation of mRNAs involved in cell cycle progression.
“Active p70S6K phosphorylates the ribosomal protein S6, enhancing translation of mRNA transcripts involved in cell cycle progression (32).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Jefferies, 1997, Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k, EMBO J source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAkt phosphorylates TSC2 at Thr1462, leading to mTORC1 activation.
“Akt directly phosphorylates TSC2 at Thr1462, resulting in activation of mTORC1 (29).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Manning, 2002, Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway, Mol Cell source
Not checked in the free run.
May combine two claims.
Interpretationown dataSCRIB overexpression is linked to aggressive breast cancer forms and poor clinical prognosis.
“These observations demonstrate that SCRIB overexpression is associated with the aggressive forms of breast cancers and with poor clinical prognosis.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown datahSCRIBP305L expression causes mammary tumors, which directly supports a causal role for SCRIB mislocalization in tumorigenesis.
“We show that expression of hSCRIBP305L induces mammary tumors, providing direct evidence that SCRIB mislocalization can have a causal role during tumorigenesis.”
Quote in the paperSubstantial claim- Rests on an assumption: The tumorigenic effect in hSCRIBP305L mice is attributable to SCRIB mislocalization rather than to SCRIB overexpression alone.
- Rests on an assumption: The hSCRIBP305L transgene is the cause of the mammary tumors, not spontaneous or insertional mutagenesis.
May combine two claims.
PremisecitationA P305L mutation in human SCRIB's LRR13 prevents membrane localization and disrupts βPIX recruitment and exocytosis.
“A specific point mutation within LRR13 (Prol 305 to Leu, P305L) of the human SCRIB protein (hSCRIB) has also been shown to abrogate membrane localization (13), disrupting recruitment of βPIX, and exocytosis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] Audebert, 2004, Mammalian Scribble forms a tight complex with the βPIX exchange factor, Curr Biol source
Not checked in the free run.
May combine two claims.
Interpretationown dataSCRIB mislocalization produces histologically diverse mammary tumors that have basal features.
“Taken together, our data provide evidence that SCRIB mislocalization induces histologically diverse mammary tumors with basal characteristics.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMislocalized SCRIB at high levels acts as a neomorph that drives mammary tumorigenesis by altering PTEN's subcellular location and turning on Akt/mTOR/S6K signaling.
“Thus, we demonstrate that high levels of mislocalized SCRIB functions as a neomorph to promote mammary tumorigenesis by affecting subcellular localization of PTEN and activating an Akt/mTOR/S6kinase signaling pathway.”
Quote in the paperSubstantial claim- Rests on an assumption: The tumorigenic effect in hSCRIBP305L mice is attributable to SCRIB mislocalization rather than to SCRIB overexpression alone.
May combine two claims.
PremisecitationIn 3D MCF-10A cultures, wild-type hSCRIB overexpression did not affect morphogenesis, but hSCRIBP305L expression led to defective morphogenesis.
“overexpression of wild-type hSCRIB in MCF-10A mammary epithelial cells grown in 3D had no impact on morphogenesis, whereas expression of hSCRIBP305L displayed defective morphogenesis (2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Zhan, 2008, Deregulation of Scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma, Cell source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe kinase mTORC2, acting in a rapamycin-insensitive complex, phosphorylates Akt at Ser473.
“Akt is also phosphorylated within the carboxyl-terminal hydrophobic motif at Ser473 by the serine/threonine kinase mammalian target of rapamycin complex 2 (mTORC2), within a rapamycin-insensitive protein complex (27).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Sarbassov, 2005, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex, Science source
Not checked in the free run.
May combine two claims.
PremisecitationScribble is required for directional migration, promotes epithelial identity, and suppresses epithelial-to-mesenchymal transition in mammary and corneal epithelial cells.
“In addition, Scribble is required for directional migration, promotes epithelial identity and suppresses epithelial to mesenchymal transition in mammary and corneal epithelial cells (4, 5, 39).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [4] Elsum, 2013, Scribble regulates an EMT polarity pathway through modulation of MAPK-ERK signaling to mediate junction formation, J Cell Sci
Not checked in the free run.
- cites [5] Yamben, 2013, Scrib is required for epithelial cell identity and prevents epithelial to mesenchymal transition in the mouse, Dev Biol source
Not checked in the free run.
- cites [39] Dow, 2007, The tumour-suppressor Scribble dictates cell polarity during directed epithelial migration: regulation of Rho GTPase recruitment to the leading edge, Oncogene source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationLoss or downregulation of SCRIB acts as a tumor suppressor by inhibiting cell death or inducing proliferation.
“Others and we have previously reported that downregulation (or loss) of SCRIB expression functions as a tumor suppressor by inhibiting cell death or inducing proliferation (2, 3).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [2] Zhan, 2008, Deregulation of Scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma, Cell source
Not checked in the free run.
- cites [3] Pearson, 2011, SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia, J Clin Invest source
Not checked in the free run.
May combine two claims.
Interpretationown dataCancer genome analysis identifies SCRIB amplification and overexpression as frequent and clinically relevant in breast cancer, rather than deletion or decreased expression.
“As we report here, large-scale cancer genome analysis identifies SCRIB gene amplification and overexpression as a frequent and clinically relevant event in breast cancer and not deletion or decrease in gene expression, raising new questions on how SCRIB may regulate the biology of cancer cells.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent analysis found that the PI3K/Akt pathway is elevated in basal-like cancers compared with luminal or HER2+ cancers.
“A recent analysis, combining mutation, mRNA expression and protein levels, determined that the PI3K/Akt pathway was elevated in basal-like cancers as compared with luminal or HER2+ (47).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Cancer Genome Atlas Network, 2012, Comprehensive molecular portraits of human breast tumours, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationThese outgrowths had increased basal markers and decreased luminal markers, similar to findings with SCRIB mislocalization.
“These outgrowths displayed increased basal markers (smooth muscle actin, CK5, CK6) and decreased luminal markers (estrogen receptor, CK18), similar to our findings with mislocalization of SCRIB.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Korkaya, 2009, Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling, PLoS Biol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationProper vesicle trafficking is critical for maintaining epithelial polarity.
“In support of this hypothesis, proper vesicle trafficking is critical for maintenance of epithelial polarity (40).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Mellman, 2008, Coordinated protein sorting, targeting and distribution in polarized cells, Nat Rev Mol Cell Biol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe gain of function from hSCRIBP305L likely drives tumorigenesis and contributes to invasive behavior in mammary tumors.
“It is likely that the gain of function associated with hSCRIBP305L drives tumorigenesis and contributes to the invasive behavior observed in mammary tumors.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMice with mammary PTEN deletion developed pathologically heterogeneous tumors with high basal marker expression.
“Mice in which PTEN was deleted within the mammary epithelium developed pathologically heterogeneous tumors with high expression of basal markers (46).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Li, 2002, Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland, Development source
Not checked in the free run.
May combine two claims.
Interpretationown dataMice overexpressing SCRIB activate a PI3K/S6K pathway and develop mammary tumors with a basal subtype.
“and that mice overexpressing SCRIB activate a PI3K/S6K pathway and induce formation of mammary tumors with the basal subtype.”
Quote in the paperSubstantial claim- Rests on an assumption: Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.
May combine two claims.
Interpretationown dataOverexpressed mislocalized SCRIB acts as a neomorph by interacting with PTEN.
“We demonstrate that overexpression of a mislocalized form of SCRIB functions as a neomorph by interacting with another tumor suppressor, PTEN, and activating an mTORC1/Akt/S6K signaling pathway in culture and in vivo.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningSCRIB normally promotes epithelial differentiation, and its loss leads to mesenchymal transition and tumorigenesis.
“Together, these observations suggest a working model that SCRIB normally promotes epithelial differentiation and loss of expression results in mesenchymal transition and tumorigenesis.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPTEN knockdown in mammary epithelial cells in 3D culture causes hyperproliferation and disrupted acinar organization.
“Furthermore, knockdown of PTEN in mammary epithelial cells grown in 3D culture results in hyperproliferation and disrupted acinar organization (37).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] Stiles, 2004, PTENless means more, Dev Biol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPTEN loss increases PIP3-mediated signaling, including Akt phosphorylation and activation.
“Loss of PTEN enhances PIP3-mediated signaling, including phosphorylation and activation of Akt (36).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Wu, 1998, The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway, Proc Natl Acad Sci U S A source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationPTEN is a phosphatase that dephosphorylates PIP3, a second messenger made by PI3K.
“PTEN is a phosphatase that dephosphorylates phosphatidylinositol (3,4,5)-trisphosphate (PIP3), a second messenger generated by phosphoinositide 3-kinase (PI3K) (35).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] Maehama, 1998, The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate, J Biol Chem source
Not checked in the free run.
The paper relies on this without support.
The tumorigenic effect in hSCRIBP305L mice is attributable to SCRIB mislocalization rather than to SCRIB overexpression alone.
“To investigate the effect of expressing Scribble that does not localize to cell-cell junctions, we generated a transgenic mouse expressing hSCRIBP305L”
The paper relies on this without support.
The hSCRIBP305L transgene is the cause of the mammary tumors, not spontaneous or insertional mutagenesis.
“Virgin hSCRIBP305L mice, but not FVB control mice, developed regions of hyperplastic growth”
The paper relies on this without support.
Akt phosphorylation at Thr308 and Ser473 is associated with increased Akt kinase activity.
“Phosphorylation of Akt at 308 and 473 is associated with an increase in its kinase activity.”
The paper relies on this without support.
SCRIB mislocalization is highly prevalent in human tumors.
“Therefore, multiple distinct mechanisms may account for the high prevalence of SCRIB mislocalization observed human tumors.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Membrane localization is key to Scrib's tumor-suppressing activity.
“The tumor-suppressive activity of Scrib correlates with its membrane localization.”
From Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1 (2023) · cites this paper as [18]
Experimental — accuracy not yet measuredEctopic expression of Scrib/P305L in cell lines enhances Akt signaling.
“Importantly, ectopic expression of Scrib/P305L in cell lines disrupts cell polarity, suppresses c-myc-induced apoptosis, enhances Akt signaling, and fails to suppress Ras-MAPK-induced EMT18,47,56,68.”
From Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1 (2023) · cites this paper as [18]
Ectopic expression of Scrib/P305L in cell lines disrupts cell polarity.
“Importantly, ectopic expression of Scrib/P305L in cell lines disrupts cell polarity, suppresses c-myc-induced apoptosis, enhances Akt signaling, and fails to suppress Ras-MAPK-induced EMT18,47,56,68.”
From Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1 (2023) · cites this paper as [18]
Transgenic mice expressing Scrib/P305L in the mammary gland display hyperplastic growth in the mammary gland and develop mammary tumors.
“Also, transgenic mice expressing Scrib/P305L in the mammary gland display hyperplastic growth in the mammary gland and develop mammary tumors18.”
From Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1 (2023) · cites this paper as [18]
Ectopic expression of Scrib/P305L in cell lines suppresses c-myc-induced apoptosis.
“Importantly, ectopic expression of Scrib/P305L in cell lines disrupts cell polarity, suppresses c-myc-induced apoptosis, enhances Akt signaling, and fails to suppress Ras-MAPK-induced EMT18,47,56,68.”
From Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1 (2023) · cites this paper as [18]
The Results section on SCRIB mislocalization and Akt reports experiments in MCF-10A cells expressing hSCRIBP305L, but does not report c-Myc-induced apoptosis. The Discussion mentions cell death in connection with prior work on SCRIB loss, not a test of whether ectopic hSCRIBP305L suppresses c-Myc-induced apoptosis. Searches for c-Myc, Myc-induced cell death, and apoptosis did not locate that finding in our copy; page numbers were unavailable. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Ectopic expression of Scrib/P305L in cell lines fails to suppress Ras-MAPK-induced EMT.
“Importantly, ectopic expression of Scrib/P305L in cell lines disrupts cell polarity, suppresses c-myc-induced apoptosis, enhances Akt signaling, and fails to suppress Ras-MAPK-induced EMT18,47,56,68.”
From Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1 (2023) · cites this paper as [18]
The Introduction says that overexpressed SCRIB suppresses EMT regulators through a Ras/MAPK-dependent mechanism, but does not make that claim for P305L. The Results section ‘SCRIB mislocalization promotes activation of Akt’ reports that P305L-expressing MCF-10A cells had ERK phosphorylation similar to wild-type SCRIB-expressing cells; it does not test whether P305L fails to suppress Ras-MAPK-induced EMT. (LLM, conf=0.72)
Experimental — accuracy not yet measuredAltered Scribble localization is associated with tumor initiation or progression in several models.
“Junctional localization of Scribble may play a tumor suppressor role, because in several models altered Scribble localization is associated with tumor initiation or progression (Feigin et al., 2014; Wan et al., 2018).”
From Scribble: A master scaffold in polarity, adhesion, synaptogenesis, and proliferation (2019) · cites this paper as Feigin et al., 2014
Conditional mammary gland knockout of Scribble did not disrupt initial gland architecture but at maturity led to ductal hyperplasia, a phenotype mimicked by an LRR point mutant.
“Similarly, conditional mammary gland knockout did not disrupt initial gland architecture but at maturity led to ductal hyperplasia (Godde et al., 2014), a phenotype mimicked by an LRR point mutant (Feigin et al., 2014).”
From Scribble: A master scaffold in polarity, adhesion, synaptogenesis, and proliferation (2019) · cites this paper as Feigin et al., 2014
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455 · see citing works
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129 · see citing works
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · see citing works
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592 · see citing works
Self-citationLi, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785 · see citing works
Györffy, B., Lanczky, A., Eklund, A. C., Denkert, C., Budczies, J., Li, Q., & Szallasi, Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0674-9 · Cited by 4,169 · see citing works
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104 · see citing works
Alessi, D., James, S., Downes, C., Holmes, A. B., Gaffney, P., Reese, C., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 3,047 · see citing works
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,742 · see citing works
Debnath, J., Muthuswamy, S. K., & Brugge, J. S. (2003) · Methods · doi:10.1016/s1046-2023(03)00032-x · Cited by 2,001 · see citing works
Self-citationThe landscape of cancer genes and mutational processes in breast cancer
Stephens, P. J., Tarpey, P. S., Davies, H. R., Loo, P. V., Greenman, C., Wedge, D. C., Nik‐Zainal, S., Martin, S., Varela, I., Bignell, G. R., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,686 · see citing works
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555 · see citing works
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A. V., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,288 · see citing works
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · see citing works
An integrative genomic and proteomic analysis of pik3ca, pten, and akt mutations in breast cancer.
Stemke-Hale, K., Gonzalez-Angulo, A. M., Lluch, A., Neve, R. M., Kuo, W.-L., Davies, M., Carey, M., Hu, Z., Guan, Y., Sahin, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6854 · Cited by 1,054 · see citing works
Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State
Guo, W., Keckesova, Z., Donaher, J. L., Shibue, T., Tischler, V., Reinhardt, F., Itzkovitz, S., Noske, A., Zürrer‐Härdi, U., Bell, G. W., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.008 · Cited by 969 · see citing works
Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
Jefferies, H. B. J., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B., & Thomas, G. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3693 · Cited by 934 · see citing works
Yudi Pawitan, Y., Bjöhle, J., Amler, L. C., Borg, A.-L., Egyházi, S., Hall, P. N., Han, X., Holmberg, L., Huang, F., Klaar, S., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1325 · Cited by 832 · see citing works
Phosphorylation and Activation of p70 <sup>s6k</sup> by PDK1
Pullen, N., Dennis, P. B., Andjelkovic, M., Dufner, A., Kozma, S. C., Hemmings, B. A., & Thomas, G. (1998) · Science · doi:10.1126/science.279.5351.707 · Cited by 826 · see citing works
Localization of apical epithelial determinants by the basolateral PDZ protein Scribble
Bilder, D., & Perrimon, N. (2000) · Nature · doi:10.1038/35001108 · Cited by 716 · see citing works
Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15587 · Cited by 674 · see citing works
Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling
Korkaya, H., Paulson, A., Charafe-Jauffret, E., Ginestier, C., Brown, M., Dutcher, J., Clouthier, S. G., & Wicha, M. S. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000121 · Cited by 523 · see citing works
Coordinated protein sorting, targeting and distribution in polarized cells
Mellman, I., & Nelson, W. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2525 · Cited by 521 · see citing works
Zhan, L., Rosenberg, A., Bergami, K. C., Yu, M., Xuan, Z., Jaffe, A. B., Allred, C., & Muthuswamy, S. K. (2008) · Cell · doi:10.1016/j.cell.2008.09.045 · Cited by 436 · see citing works
Self-citationIdentification of a Proline-rich Akt Substrate as a 14-3-3 Binding Partner
Kovacina, K. S., Park, G. Y., Bae, S. S., Guzzetta, A. W., SCHAEFER, E. M., Birnbaum, M. J., & Roth, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210837200 · Cited by 361 · see citing works
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
Chen, X., Li, J., Gray, W. H., Lehmann, B. D., Bauer, J. A., Shyr, Y., & Pietenpol, J. A. (2012) · Cancer Informatics · doi:10.4137/cin.s9983 · Cited by 292 · see citing works
Self-citationA gene expression signature identifies two prognostic subgroups of basal breast cancer
Sabatier, R., Finetti, P., Cervera, N., Lambaudie, É., Esterni, B., Mamessier, É., Tallet, A. R., Chabannon, C., Extra, J.-M., Jacquemier, J. D., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0897-9 · Cited by 283 · see citing works
Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland
Li, G., Robinson, G. W., Lesche, R., Martinez-Diaz, H., Jiang, Z., Rozengurt, N., Wagner, K.-U., Wu, D.-C., Lane, T. F., Liu, X., et al. (2002) · Development · doi:10.1242/dev.129.17.4159 · Cited by 272 · see citing works
Junctional recruitment of mammalian Scribble relies on E-cadherin engagement
Navarro, C., Nola, S., Audebert, S., Santoni, M.-J., Arsanto, J.-P., Ginestier, C., Marchetto, S., Jacquemier, J., Isnardon, D., Le Bivic, A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208632 · Cited by 237 · see citing works
Stiles, B., Groszer, M., Wang, S., Jiao, J., & Wu, H. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.06.008 · Cited by 230 · see citing works
Mammalian Scribble Forms a Tight Complex with the βPIX Exchange Factor
Audebert, S., Navarro, C., Nourry, C., Chasserot-Golaz, S., Lécine, P., Bellaiche, Y., Dupont, J.-L., Premont, R. T., Sempéré, C., Strub, J.-M., et al. (2004) · Current Biology · doi:10.1016/j.cub.2004.05.051 · Cited by 218 · see citing works
Dow, L. E., Kauffman, J. S., Caddy, J., Peterson, A. S., Jane, S. M., Russell, S. M., & Humbert, P. O. (2007) · Oncogene · doi:10.1038/sj.onc.1210016 · Cited by 187 · see citing works
Pearson, H. B., Perez-Mancera, P. A., Dow, L. E., Ryan, A., Tennstedt, P., Bogani, D., Elsum, I., Greenfield, A., Tuveson, D. A., Simon, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58509 · Cited by 185 · see citing works
Mammary gland involution is delayed by activated Akt in transgenic mice
Schwertfeger, K. L., Richert, M. M., & Anderson, S. M. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.6.0663 · Cited by 169 · see citing works
Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development
Skouloudaki, K., Puetz, M., Simons, M., Courbard, J.-R., Boehlke, C., Hartleben, B., Engel, C., Moeller, M. J., Englert, C., Bollig, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811691106 · Cited by 163 · see citing works
Werme, K., Wigerius, M., & Johansson, M. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01076.x · Cited by 158 · see citing works
Zeitler, J., Hsu, C. P., Dionne, H., & Bilder, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200407158 · Cited by 135 · see citing works
Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators
Huang, L., & Muthuswamy, S. K. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.12.001 · Cited by 132 · see citing works
Self-citationZarbalis, K., May, S. R., Shen, Y., Ekker, M., Rubenstein, J. L. R., & Peterson, A. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020219 · Cited by 130 · see citing works
Anastas, J. N., Biechele, T. L., Robitaille, M., Muster, J., Allison, K. H., Angers, S., & Moon, R. T. (2011) · Oncogene · doi:10.1038/onc.2011.528 · Cited by 126 · see citing works
Wilson, K. S., Roberts, H., Leek, R., Harris, A. L., & Geradts, J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64394-5 · Cited by 107 · see citing works
Elsum, I. A., Martin, C., & Humbert, P. O. (2013) · Journal of Cell Science · doi:10.1242/jcs.129387 · Cited by 87 · see citing works
NOS1AP associates with Scribble and regulates dendritic spine development
Richier, L., Williton, K., Clattenburg, L., Colwill, K., O'Brien, M., Tsang, C., Kolar, A., Zinck, N., Metalnikov, P., Trimble, W. S., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3726-09.2010 · Cited by 81 · see citing works
Scribble‐mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt
Li, X., Yang, H., Liu, J., Schmidt, M. D., & Gao, T. (2011) · EMBO Reports · doi:10.1038/embor.2011.106 · Cited by 79 · see citing works
Yamben, I. F., Rachel, R. A., Shatadal, S., Copeland, N. G., Jenkins, N. A., Warming, S., & Griep, A. E. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.09.027 · Cited by 50 · see citing works
The Retinoblastoma Gene Undergoes Rearrangements in BRCA1 -Deficient Basal-like Breast Cancer
Jönsson, G. B., Staaf, J., Vallon‐Christersson, J., Ringnér, M., Gruvberger-Saal, S. K., Saal, L. H., Holm, K., Hegardt, C., Arason, A., Fagerholm, R., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0097 · Cited by 49 · see citing works
Renner, O., Blanco-Aparicio, C., Grassow, M., Cañamero, M., Leal, J. F. M., & Carnero, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1539 · Cited by 44 · see citing works
Metodieva, G., Nogueira-de-Souza, N. C., Greenwood, C., Al-Janabi, K., Leng, L., Bucala, R., & Metodiev, M. V. (2013) · Neoplasia · doi:10.1593/neo.13464 · Cited by 40 · see citing works
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The role of lipids in cancer progression and metastasis
Martín‐Pérez, M., Urdiroz-Urricelqui, U., Bigas, C., & Benitah, S. A. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.023 · Cited by 577 · see citing works
Cell motility in cancer invasion and metastasis: insights from simple model organisms
Stuelten, C. H., Parent, C. A., & Montell, D. J. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2018.15 · Cited by 510 · see citing works
Won, S. J., Kit, M. C. S., & Martin, B. R. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1409191 · Cited by 193 · see citing works
Self-citationCell polarity signaling in the plasticity of cancer cell invasiveness
Gandalovičová, A., Vomastek, T., Rösel, D., & Brábek, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7214 · Cited by 149 · see citing works
Scribble: A master scaffold in polarity, adhesion, synaptogenesis, and proliferation
Bonello, T. T., & Peifer, M. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201810103 · Cited by 127 · see citing works
“Similarly, conditional mammary gland knockout did not disrupt initial gland architecture but at maturity led to ductal hyperplasia (Godde et al., 2014), a phenotype mimicked by an LRR point mutant (Feigin et al., 2014).”
BackgroundThe Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy
Ganti, K., Broniarczyk, J. K., Manoubi, W., Massimi, P., Mittal, S., Pim, D., Szalmás, A., Thatte, J. V., Thomas, M., Tomaić, V., et al. (2015) · Viruses · doi:10.3390/v7072785 · Cited by 134 · see citing works
Stephens, R., Lim, K., Portela, M., Kvansakul, M., Humbert, P. O., & Richardson, H. E. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.011 · Cited by 132 · see citing works
The interdependence of the Rho GTPases and apicobasal cell polarity
Mack, N. A., & Γεωργίου, Μ. (2014) · Small GTPases · doi:10.4161/21541248.2014.973768 · Cited by 132 · see citing works
ZDHHC7-mediated S-palmitoylation of Scribble regulates cell polarity
Chen, B., Zheng, B., DeRan, M., Jarugumilli, G. K., Fu, J., Brooks, Y. S., & Wu, X. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2119 · Cited by 119 · see citing works
The molecular basis of mammary gland development and epithelial differentiation
Slepicka, P. F., Somasundara, A. V. H., & dos Santos, C. O. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.09.014 · Cited by 112 · see citing works
The transcriptional response to tumorigenic polarity loss in Drosophila
Bunker, B. D., Nellimoottil, T. T., Boileau, R. M., Classen, A. K., & Bilder, D. (2015) · eLife · doi:10.7554/elife.03189 · Cited by 114 · see citing works
Wang, S., Lee, C., Lin, M., Chi, C., Chen, Y.-J., Wang, G.-S., Liao, K., Chiu, L.-P., Wu, S.-H., Huang, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051612 · Cited by 110 · see citing works
Yang, Q., Zhong, S., He, L., Jia, X., Tang, H., Cheng, S., Ren, J., Yu, H., Zhou, L., Zhou, H., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.028 · Cited by 106 · see citing works
Adachi, Y., Kimura, R., Hirade, K., Yanase, S., Nishioka, Y., Kasuga, N., Yamaguchi, R., & Ebi, H. (2023) · Nature Cancer · doi:10.1038/s43018-023-00575-2 · Cited by 93 · see citing works
Zhao, Y., Wang, J., Xu, C., Li, Y., Sun, B., & Yang, L. (2019) · Clinical Science · doi:10.1042/cs20190225 · Cited by 90 · see citing works
Khalil, S., Delehanty, L. L., Grado, S., Holy, M., White, Z., Freeman, K. C., Kurita, R., Nakamura, Y., Bullock, G. C., & Goldfarb, A. N. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170396 · Cited by 86 · see citing works
APT2 Inhibition Restores Scribble Localization and S -Palmitoylation in Snail-Transformed Cells
Hernandez, J. L., Davda, D., Kit, M. C. S., Majmudar, J. D., Won, S. J., Gang, M., Pasupuleti, S. C., Choi, A. I., Bartkowiak, C. M., & Martin, B. R. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2016.12.007 · Cited by 80 · see citing works
Self-citationViral Interactions with PDZ Domain-Containing Proteins—An Oncogenic Trait?
James, C. D., & Roberts, S. (2016) · Pathogens · doi:10.3390/pathogens5010008 · Cited by 80 · see citing works
Wan, S., Meyer, A., Weiler, S. M. E., Rupp, C., Tóth, M., Sticht, C., Singer, S., Thomann, S., Roessler, S., Schorpp‐Kistner, M., et al. (2018) · Hepatology · doi:10.1002/hep.29669 · Cited by 79 · see citing works
Wnt/Planar Cell Polarity Signaling: New Opportunities for Cancer Treatment
Daulat, A. M., & Borg, J. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.01.001 · Cited by 78 · see citing works
Thomas, M., Myers, M. P., Massimi, P., Guarnaccia, C., & Banks, L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005766 · Cited by 73 · see citing works
Zheng, W., Umitsu, M., Jagan, I., Tran, C. W., Ishiyama, N., BeGora, M., Araki, K., Ohashi, P. S., Ikura, M., & Muthuswamy, S. K. (2016) · Nature Cell Biology · doi:10.1038/ncb3413 · Cited by 60 · see citing works
Self-citationWang, X., Dong, B., Zhang, K., Ji, Z., Cheng, C., Zhao, H., Sheng, Y., Li, X., Fan, L., Xue, W., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007609 · Cited by 66 · see citing works
The Scribble family in cancer: twentieth anniversary
Santoni, M.-J., Kashyap, R., Camoin, L., & Borg, J.-P. (2020) · Oncogene · doi:10.1038/s41388-020-01478-7 · Cited by 62 · see citing works
Reinterpreting polarity and cancer: The changing landscape from tumor suppression to tumor promotion
Saito, Y., Desai, R., & Muthuswamy, S. K. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.001 · Cited by 66 · see citing works
Self-citationCell polarity changes in cancer initiation and progression
Péglion, F., & Etienne‐Manneville, S. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202308069 · Cited by 63 · see citing works
Progressive polarity loss and luminal collapse disrupt tissue organization in carcinomaPreprint
Halaoui, R., Rejon, C. A., Chatterjee, S. J., Szymborski, J., Meterissian, S. H., Muller, W. J., Ömeroğlu, A., & McCaffrey, L. M. (2017) · Genes & Development · doi:10.1101/gad.300566.117 · Cited by 61 · see citing works
Salicylic Acid Regulates Pollen Tip Growth through an NPR3/NPR4-Independent Pathway
Rong, D., Luo, N., Mollet, J., Liu, X., & Yang, Z. (2016) · Molecular Plant · doi:10.1016/j.molp.2016.07.010 · Cited by 57 · see citing works
Wang, N., Song, L., Xu, Y., Zhang, L., Wu, Y., Guo, J., Ji, W., Li, L., Zhao, J., Zhang, X., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.057 · Cited by 55 · see citing works
Insight into planar cell polarity
Sebbagh, M., & Borg, J. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.005 · Cited by 51 · see citing works
Tenvooren, I., Jenks, M. Z., Rashid, H., Cook, K. L., Mühlemann, J. K., Sistrunk, C., Holmes, J., Wang, K., Bonin, K., Hodges, K. B., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0687-8 · Cited by 47 · see citing works
SCRIB Promotes Proliferation and Metastasis by Targeting Hippo/YAP Signalling in Colorectal Cancer
Shen, H., Huang, C., Wu, J., Li, J., Hu, T., Wang, Z., Zhang, H., Shao, Y., & Fu, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.656359 · Cited by 40 · see citing works
Djeungoue‐Petga, M., Lurette, O., Jean, S., Hamel-Côté, G., Martín-Jiménez, R., Bou, M., Cannich, A., Roy, P., & Hébert-Chatelain, É. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2134-8 · Cited by 41 · see citing works
Expression of Polarity Genes in Human Cancer
Lin, W., Asmann, Y. W., & Anastasiadis, P. Z. (2015) · Cancer Informatics · doi:10.4137/cin.s18964 · Cited by 41 · see citing works
The cell polarity protein Scrib functions as a tumor suppressor in liver cancer
Kapil, S., Sharma, B. K., Patil, M., Elattar, S., Yuan, J., Hou, X. S., Kolhe, R. B., & Ande, S. (2017) · Oncotarget · doi:10.18632/oncotarget.15713 · Cited by 40 · see citing works
Lim, K. Y. B., Gödde, N. J., Humbert, P. O., & Kvansakul, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.799452 · Cited by 34 · see citing works
Cancer driver candidate genes AVL9, DENND5A and NUPL1 contribute to MDCK cystogenesis
Li, Y., Xu, J., Xiong, H., Ma, Z., Wang, Z., Kipreos, E. T., Dalton, S., & Zhao, S. (2014) · Oncoscience · doi:10.18632/oncoscience.107 · Cited by 35 · see citing works
Schnerch, D., & Nigg, E. A. (2015) · Oncogene · doi:10.1038/onc.2015.332 · Cited by 35 · see citing works
Che, X., YAN, H. H., Sun, H., Dongol, S., Wang, Y., Lv, Q., & Jiang, J. (2016) · Oncology Reports · doi:10.3892/or.2016.4840 · Cited by 32 · see citing works
The polarity protein Scribble positions DLC3 at adherens junctions to regulate Rho signaling
Hendrick, J., Franz-Wachtel, M., Moeller, Y., Schmid, S., Macek, B., & Olayioye, M. A. (2016) · Journal of Cell Science · doi:10.1242/jcs.190074 · Cited by 32 · see citing works
Fostok, S. F., El‐Sibai, M., Bazzoun, D., Lelièvre, S. A., & Talhouk, R. (2019) · Cancers · doi:10.3390/cancers11030339 · Cited by 32 · see citing works
Artuso, I., Lidonnici, M. R., Altamura, S., Mandelli, G., Pettinato, M., Muckenthaler, M. U., Silvestri, L., Ferrari, G., Camaschella, C., & Nai, A. (2018) · Blood · doi:10.1182/blood-2018-05-852277 · Cited by 38 · see citing works
Upsetting the Balance: When Viruses Manipulate Cell Polarity Control
Thomas, M., & Banks, L. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.016 · Cited by 30 · see citing works
LIN7A is a major determinant of cell-polarity defects in breast carcinomas
Gruel, N., Fuhrmann, L., Lodillinsky, C., Benhamo, V., Mariani, O., Cédenot, A., Arnould, L., MacGrogan, G. M., Sastre‐Garau, X., Chavrier, P., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0680-x · Cited by 29 · see citing works
Rives-Quinto, N., Franco, M., de Torres-Jurado, A., & Carmena, A. (2017) · Development · doi:10.1242/dev.148171 · Cited by 26 · see citing works
Emerging roles for LPP in metastatic cancer progression
Ngan, E., Kiepas, A., Brown, C. M., & Siegel, P. M. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0415-5 · Cited by 28 · see citing works
Kranjec, C., Tomaić, V., Massimi, P., Nicolaides, L., Doorbar, J., & Banks, L. (2016) · Papillomavirus Research · doi:10.1016/j.pvr.2016.04.001 · Cited by 28 · see citing works
The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/β-Catenin Signaling
Almeida, L. L., Sebbagh, M., Bertucci, F., Finetti, P., Wicinski, J., Marchetto, S., Castellano, R., Josselin, E., Charafe‐Jauffret, E., Ginestier, C., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.09.008 · Cited by 27 · see citing works
Drosophila Models of Cell Polarity and Cell Competition in Tumourigenesis
Fahey-Lozano, N., Marca, J. E. L., Portela, M., & Richardson, H. E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-23629-8_3 · Cited by 27 · see citing works
Cell Polarity Proteins in Breast Cancer Progression
Rejon, C. A., Al‐Masri, M., & McCaffrey, L. M. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25553 · Cited by 26 · see citing works
Dissecting the role of polarity regulators in cancer through the use of mouse models
Gödde, N., Pearson, H. B., Smith, L. K., & Humbert, P. O. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.036 · Cited by 25 · see citing works
FAM83H and SCRIB stabilize β-catenin and stimulate progression of gastric carcinoma
Hussein, U. K., Ha, S. H., Ahmed, A. G., Kim, K. M., Park, S., Kim, C. Y., Kwon, K. S., Zhang, Z., Lee, S., Park, H. S., et al. (2020) · Aging · doi:10.18632/aging.103351 · Cited by 24 · see citing works
Scribble sub-cellular localization modulates recruitment of YES1 to regulate YAP1 phosphorylation
Zhao, D., Yin, Z., Soellner, M. B., & Martin, B. R. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.02.019 · Cited by 22 · see citing works
Self-citationPeng, Y., Liu, X., Jin, Z., Liu, H., & Xu, C. (2021) · Human Reproduction · doi:10.1093/humrep/deab234 · Cited by 22 · see citing works
Regulation of cellular and PCP signalling by the Scribble polarity module
Milgrom-Hoffman, M., & Humbert, P. O. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.11.021 · Cited by 22 · see citing works
Modeling Tissue Polarity in Context
Tharp, K. M., & Weaver, V. M. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.07.015 · Cited by 20 · see citing works
Saito, Y., Matsuda, S., Ohnishi, N., Endo, K., Ashitani, S., Ohishi, M., Ueno, A., Tomita, M., Ueda, K., Soga, T., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03363-3 · Cited by 20 · see citing works
Self-citationScribble acts as an oncogene in Eμ-myc-driven lymphoma
Hawkins, E. D., Oliaro, J., Ramsbottom, K. M., Newbold, A., Humbert, P. O., Johnstone, R. W., & Russell, S. M. (2015) · Oncogene · doi:10.1038/onc.2015.167 · Cited by 19 · see citing works
Erbin loss promotes cancer cell proliferation through feedback activation of Akt-Skp2-p27 signaling
Huang, H., Song, Y., Wu, Y., Guo, N., Yuan-fang Ma, A., & Lü, Q. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.071 · Cited by 19 · see citing works
Catterall, R., Lelarge, V., & McCaffrey, L. M. (2019) · International Journal of Cancer · doi:10.1002/ijc.32691 · Cited by 18 · see citing works
Mapping the Polarity Interactome
Pires, H. R., & Boxem, M. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.12.017 · Cited by 19 · see citing works
The Scribble–Dlg–Lgl Module in Cell Polarity Regulation
Humbert, P. O., Russell, S. M., Smith, L. K., & Richardson, H. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-14463-4_4 · Cited by 17 · see citing works
Spectrin binding motifs regulate Scribble cortical dynamics and polarity function
Boëda, B., & Etienne‐Manneville, S. (2015) · eLife · doi:10.7554/elife.04726 · Cited by 16 · see citing works
The Tumor Suppressor SCRIB is a Negative Modulator of the Wnt/β‐Catenin Signaling Pathway
Daulat, A. M., Wagner, M. S., Walton, A., Baudelet, É., Audebert, S., Camoin, L., & Borg, J. (2019) · PROTEOMICS · doi:10.1002/pmic.201800487 · Cited by 15 · see citing works
Defining bone fide effectors of RAS GTPases
Smith, M. J. (2023) · BioEssays · doi:10.1002/bies.202300088 · Cited by 12 · see citing works
Scribble, Lgl1, and myosin II form a complex in vivo to promote directed cell migration
Abedrabbo, M., & Ravid, S. (2020) · Molecular Biology of the Cell · doi:10.1091/mbc.e19-11-0657 · Cited by 12 · see citing works
The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?
Thomas, M., & Banks, L. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.09.011 · Cited by 12 · see citing works
Stearoylation cycle regulates the cell surface distribution of the PCP protein Vangl2
Ying, J., Yang, Y., Zhang, X., Dong, Z., & Chen, B. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2400569121 · Cited by 11 · see citing works
Metodieva, G., Adoki, S., Lausen, B., & Metodiev, M. V. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.05.009 · Cited by 11 · see citing works
Hussein, U. K., Ahmed, A. G., Choi, W. K., Kim, K. M., Park, S., Park, H. S., Noh, S. J., Lee, H., Chung, M. J., Moon, W. S., et al. (2021) · Biomolecules · doi:10.3390/biom11030405 · Cited by 11 · see citing works
Endomembrane control of cell polarity: Relevance to cancer
Baschieri, F., & Farhan, H. (2015) · Small GTPases · doi:10.1080/21541248.2015.1018402 · Cited by 11 · see citing works
Edamana, S., Login, F. H., Riishede, A., Dam, V. S., Tramm, T., & Nejsum, L. N. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00311.2022 · Cited by 10 · see citing works
Voutsadakis, I. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020411 · Cited by 10 · see citing works
Mapping Cellular Polarity Networks Using Mass Spectrometry-based Strategies
Daulat, A. M., Puvirajesinghe, T. M., Camoin, L., & Borg, J. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.023 · Cited by 9 · see citing works
Murillo, L. L., Green, M., Mahon, N., Saiani, A., & Tsigkou, O. (2025) · Cancers · doi:10.3390/cancers17101675 · Cited by 8 · see citing works
Mechanisms of polarity protein expression control
Ahmed, S. M., & Macara, I. G. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.04.002 · Cited by 8 · see citing works
Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1
Thüring, E.-M., Hartmann, C., Maddumage, J. C., Javorsky, A., Michels, B. E., Gerke, V., Banks, L., Humbert, P. O., Kvansakul, M., & Ebnet, K. (2023) · Communications Biology · doi:10.1038/s42003-023-05088-3 · Cited by 7 · see citing works
ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer
Yao, L., Li, Y., Li, S., Wang, M., Cao, H., Xu, L., & Xu, Y. (2023) · BMC Cancer · doi:10.1186/s12885-023-10904-4 · Cited by 7 · see citing works
Sharma, M., & Dey, C. S. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00987-0 · Cited by 7 · see citing works
Marca, J. E. L., Ely, R. W., Diepstraten, S. T., Burke, P., Kelly, G. L., Humbert, P. O., & Richardson, H. E. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049769 · Cited by 7 · see citing works
Spatial Rho regulation: Molecular mechanisms controlling the GAP protein DLC3
Hendrick, J., & Olayioye, M. A. (2016) · Small GTPases · doi:10.1080/21541248.2016.1260673 · Cited by 7 · see citing works
Cellular polarity pilots breast cancer progression and immunosuppression
Huang, J., Luo, S., Shen, J., Lee, M., Chen, R., Ma, S., Sun, L., & Li, J. J. (2025) · Oncogene · doi:10.1038/s41388-025-03324-0 · Cited by 6 · see citing works
Jin, Z., Wang, J., & Chen, Y. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01319-4 · Cited by 6 · see citing works
Body mass index and γ-glutamyl transferase expression in normal and cancerous breast tissue
Coradini, D., Gambazza, S., Oriana, S., & Ambrogi, F. (2020) · Breast Cancer · doi:10.1007/s12282-020-01080-5 · Cited by 6 · see citing works
Lulić, L., Jakovčević, A., Manojlović, L., Dediol, E., Banks, L., & Tomaić, V. (2021) · Cancers · doi:10.3390/cancers13174461 · Cited by 6 · see citing works
Andolfi, C., Tiribelli, C., & Pascut, D. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2705164 · Cited by 6 · see citing works
Systematic analysis reveals tumor-enhancing and -suppressing microRNAs inDrosophilaepithelial tumors
Shu, Z., Huang, Y., Palmer, W. H., Tamori, Y., Xie, G., Wang, H., Liu, N., & Deng, W. (2017) · Oncotarget · doi:10.18632/oncotarget.22226 · Cited by 6 · see citing works
Epithelial Membrane Protein 2 and β1 integrin signaling regulate APC-mediated processes
Lesko, A. C., & Prosperi, J. R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.021 · Cited by 6 · see citing works
Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo‐Rodríguez, C., Henríquez, J. A., Caligiuri, G., Teles, S. P., Park, Y., Evans, A., Barrera, L. N., Neeße, A., Grützmann, R., Aust, D. E., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3419 · Cited by 5 · see citing works
Polarity in breast development and cancer
Whitford, M. K., & McCaffrey, L. M. (2023) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2023.02.009 · Cited by 6 · see citing works
Manning, L., Holmes, J., Bonin, K., & Vidi, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2019.00314 · Cited by 4 · see citing works
AVL9 promotes colorectal carcinoma cell migration via regulating EGFR expression
Wu, Q., Chen, J. D., & Zhou, Z. (2022) · Biological Procedures Online · doi:10.1186/s12575-021-00162-8 · Cited by 4 · see citing works
Segurado, A., Rodríguez-Carrillo, A., Castellanos, B., Hernández-Galilea, E., Velasco, A., & Lillo, C. (2022) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2022.983151 · Cited by 3 · see citing works
Kumar, R., & Srikrishna, S. (2024) · Developmental Biology · doi:10.1016/j.ydbio.2024.09.005 · Cited by 3 · see citing works
Wang, B., Zhang, X., Han, X., Hao, B., Li, Y., & Guo, X. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae055 · Cited by 3 · see citing works
Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer
Shen, H., Meng, Y., Hu, T., Li, S., Du, M., Xin, J., Gu, D., Wang, M., & Fu, Z. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02910-3 · Cited by 3 · see citing works
Integrated profiling reveals polarity protein dysregulation during oral cancer progression
Ghose, S., Chaudry, U. R., Chakravarty, S., Sarangi, S., Biswas, N. K., Baral, R., & Ray, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-27447-2 · Cited by 2 · see citing works
He, X., Peng, Y., Liu, H., & Xu, C. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114654 · Cited by 2 · see citing works
Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression
Hirose, K., Masuda, T., Otsu, H., Tobo, T., Hosoda, K., Abe, T., Nakano, Y., Hashimoto, M., Tatsumi, T., Ikehara, T., et al. (2025) · Cancer Science · doi:10.1111/cas.70119 · Cited by 2 · see citing works
Poindexter, S. V. (2015) · Cited by 1 · see citing works
- Authors
- Feigin, M. E., Akshinthala, S. D., Araki, K., Rosenberg, A. Z., Muthuswamy, L. B., Martin, B., Lehmann, B. D., Berman, H. K., Pietenpol, J. A., Cardiff, R. D., & Muthuswamy, S. K.
- Affiliations
- Ontario Institute for Cancer Research (CA)
- Corresponding author
- Muthuswamy, Senthil K.
- ORCID
- Venue
- Cancer Research
- Published
- 2014-05-29
- Volume
- 74
- Issue
- 11
- Pages
- 3180-3194
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC4096808
- OpenAlex
- W2107089643
- Cited by
- 135
- References
- 49
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 5 · 2023: 11 · 2022: 15 · 2021: 6 · 2020: 9 · 2019: 14 · 2018: 11 · 2017: 16 · 2016: 16 · 2015: 11 · 2014: 4
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Cancer Institute (CA105388, U01CA105388, CA098830, R56CA098830, P30CA093373, R01CA098830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Keywords
- Scribble, SCRIB, breast cancer, basal-like breast cancer, cell polarity, cell-cell contact, protein mislocalization, PTEN, PI3K signaling, mammary carcinogenesis, tumor suppressor, epithelial differentiation, transgenic mice
- MeSH terms
- Animals, Breast Neoplasms, Cell Line, Female, Humans, Membrane Proteins, Mice, Transgenic, Signal Transduction, Gene Expression, Cell Polarity, Phosphatidylinositol 3-Kinases, Tumor Suppressor Proteins, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Mice, HEK293 Cells, Class I Phosphatidylinositol 3-Kinases, TOR Serine-Threonine Kinases, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-09-30.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-30.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review